Article
KRAS and BRAF mutations in patients with rectal cancer treated with preoperative chemoradiotherapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology - 1 Jan 2010
Gaedcke Jochen, Grade Marian, Jung Klaus, Schirmer Markus, Jo Peter, Obermeyer Christoph, Wolff Hendrik A, Herrmann Markus K, Beissbarth Tim, Becker Heinz, Ried Thomas, Ghadimi Michael
Abstract excerpt
BACKGROUND AND PURPOSE: KRAS and BRAF are mutated in 35% and 10% of colorectal cancers, respectively. However, data specifically for locally advanced rectal cancers are scarce, and the frequency of KRAS mutations in codons 61 and 146 remains to be established. MATERIALS AND METHODS: DNA was isolated from pre-therapeutic biopsies of 94 patients who were treated within two phase-III clinical trials receiving...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
